Reta Pro 10mg – Advanced Dual-Peptide Metabolic & Weight Management Support

Reta Pro is an advanced research peptide blend combining Retatrutide 5mg + Cagrilintide 5mg in one formulation. These two compounds target different pathways involved in appetite, satiety, energy balance, glucose metabolism, and body-weight regulation, making this combination of particular interest in metabolic and weight-management research.

Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors. It is being studied for its effects on appetite, body weight, glucose regulation, and energy metabolism. Cagrilintide is a long-acting amylin analogue being investigated for its ability to increase feelings of fullness, reduce hunger, and support lower food intake.

Together, Reta Pro provides a multi-pathway approach for research focused on appetite regulation, metabolic health, and body composition.

Potential Research Benefits of Reta Pro

Supports appetite and hunger regulation
May help reduce cravings and "food noise"
Promotes increased satiety and feeling satisfied with smaller portions
Supports healthy weight-management research
May support reductions in body fat and improved body composition
Supports glucose and metabolic regulation
Targets multiple pathways involved in energy balance and weight regulation
May help support long-term metabolic wellness when paired with appropriate nutrition, activity, and lifestyle habits

Who May Be Interested in Reta Pro?

Reta Pro may be of interest in research involving:

Weight management and body composition
Persistent hunger or difficulty feeling satisfied
Food cravings and appetite regulation
Metabolic health
Glucose regulation
Fat metabolism
Multi-pathway approaches to weight-management research

Why Reta Pro Is Different

Most metabolic compounds focus primarily on one or two signaling pathways. Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, while Cagrilintide targets the amylin pathway.

This means the two compounds approach appetite and metabolic regulation through different biological mechanisms. Retatrutide is being investigated for broad effects on weight and metabolic function, while Cagrilintide is being investigated particularly for its effects on satiety and appetite.

This complementary mechanism is what makes the Reta + Cagri combination especially interesting for advanced metabolic research.

What's Included

Retatrutide – 5mg A triple GLP-1/GIP/glucagon receptor agonist currently under clinical investigation for obesity, metabolic health, and weight management.

Cagrilintide – 5mg A long-acting amylin analogue currently being investigated for appetite regulation, increased satiety, and weight management.

Total Blend: 10mg

Important Research Information

Retatrutide and cagrilintide are investigational compounds. While each has been studied clinically, the Reta Pro 5mg/5mg compounded blend itself should not be represented as an FDA-approved weight-loss treatment or as having established clinical outcomes equivalent to studies of the individual compounds.

Research Use Disclaimer

This product is intended for research purposes only and is not for human consumption.

Hey there—welcome in!

A simple, non-injectable way to support fat loss, energy, and recovery with daily peptide nutrition.